Clovis Oncology Inc. sell Marianka
Start price
06.04.22
/
70%
€2.64
Target price
06.04.23
€1.00
Performance (%)
-22.00%
End price
18.04.22
€2.06
Summary
This prediction ended on 18.04.22 with a price of €2.06. The prediction for Clovis Oncology Inc. closed with a convincing performance of -22.00%. Marianka has 70% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Clovis Oncology Inc. | - | - | - |
| iShares Core DAX® | -0.922% | -1.993% | 13.399% |
| iShares Nasdaq 100 | 0.371% | -0.868% | 41.541% |
| iShares Nikkei 225® | 2.224% | -5.187% | 20.497% |
| iShares S&P 500 | -0.026% | -0.918% | 30.410% |
According to Marianka what are the pros and cons of Clovis Oncology Inc. for the foreseeable future?
Pros
Good culture
Cons
Probably not worthwhile Investment
Decining EBIT margin than peer group
overvalued
Very low/no dividend yield expected
Bad rating
Little Investments for future growth
High risks in the balance sheet
ROE lower than 5% per year
Deficits in Management
Dependend from some customers or products
Growths slower than the competition
Sustainability is little important
Below average Marketposition
Business model of the past or high risk
Revenue decline/stagnation expected
EBIT decline/stagnation expected
High challenges to pay loans and raise capital
Little innovation
Few uniques
Higher risks for its business
high free float
Significant cyclical dependencies
Little known brand
negative Cash Flow expected
Comments by Marianka for this prediction
In the thread Clovis Oncology Inc. diskutieren
Sell mit Kursziel 1,0